Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
27.81
+0.16 (0.58%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Anbio Biotechnology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 6.4 | 2.37 | 2.25 | 10.01 | 2.54 |
| Depreciation & Amortization | - | - | 0.01 | 0.01 | - |
| Loss (Gain) From Sale of Investments | 0.07 | -0.34 | -0.16 | -0.04 | - |
| Change in Accounts Receivable | -2.59 | 0.82 | -1.88 | 0.72 | -0.72 |
| Change in Inventory | - | - | 0.35 | -0.35 | - |
| Change in Accounts Payable | -1.63 | 0.8 | -0.58 | -0.48 | 1.89 |
| Change in Other Net Operating Assets | -8.99 | -1.57 | 0.91 | -5.41 | 0.47 |
| Operating Cash Flow | -6.74 | 2.08 | 0.9 | 4.45 | 4.18 |
| Operating Cash Flow Growth | - | 131.57% | -79.81% | 6.40% | - |
| Investment in Securities | -4.2 | 0.34 | 1.73 | -1.53 | - |
| Investing Cash Flow | -4.2 | 0.34 | 1.73 | -1.53 | - |
| Issuance of Common Stock | 7.23 | - | - | - | - |
| Other Financing Activities | -0.28 | -0.34 | -0.04 | - | - |
| Financing Cash Flow | 6.95 | -0.34 | -0.04 | - | - |
| Net Cash Flow | -3.99 | 2.07 | 2.59 | 2.92 | 4.18 |
| Levered Free Cash Flow | -9.61 | 1.27 | 0.03 | 0.87 | - |
| Unlevered Free Cash Flow | -9.61 | 1.27 | 0.03 | 0.87 | - |
| Change in Working Capital | -13.21 | 0.04 | -1.2 | -5.53 | 1.65 |
Source: S&P Capital IQ. Standard template.
Financial Sources.